Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: Virulent transmissible strains of genomovar III can replace Burkholderia multivorans

Clinical Infectious Diseases

Volumn 33, Issue 9, 2001, Pages 1469-1475

  Mahenthiralingam, Eshwar ^a   Vandamme, Peter ^b   Campbell, Maureen E ^a   Henry, Deborah A ^a   Gravelle, Anna M ^a   Wong, Lawrence T K ^a   Davidson, A George F ^a   Wilcox, Pearce G ^a   Nakielna, Barbara ^a   Speert, David P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA STABILIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE SEVERITY; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; BRITISH COLUMBIA; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD; CYSTIC FIBROSIS; HUMANS; PREVALENCE; VIRULENCE;

EID: 0035503325     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322684     Document Type: Article

References (30)

1. Proposal of the Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.
2. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
3. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
4. Burkholderia cepacia: Management issues and new insights
5. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: Nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers
6. + Pseudomonas (Burkholderia) cepacia causing epidemics in North America and Britain
7. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by random amplified polymorphic DNA (RAPD) fingerprinting
8. Identification and characterization of a novel DNA marker associated with epidemic strains of Burkholderia cepacia recovered from patients with cystic fibrosis
9. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
10. Home-use nebulizers: A potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis
11. Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multi-resistant Pseudomonas aeruginosa
12. Transmissibility and infection control implications of Burkholderia cepacia
13. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients: Proposal of Burkholderia multivorans sp. nov
14. Taxonomic note: A pragmatic approach to the nomenclature of phenotypically similar genomic groups
15. Identification and population structure of Burkholderia stabilis sp. nov (formerly Burkholderia cepacia genomovar IV)
16. Determinants of mortality from cystic fibrosis in Canada, 1970-1989
17. Identification of Burkholderia cepacia from patients with cystic fibrosis and a new selective medium for its isolation
18. A diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex
19. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
20. Burkholderia cepacia in cystic fibrosis: Variable disease course
21. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex bacterial pathogens: Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, Burkholderia cepacia genomovar I and Burkholderia cepacia genomovar III
22. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis
23. Pseudomonas cepacia in cystic fibrosis lung transplant recipients and clinic patients
24. Multiple replicons constituting the genome of Pseudomonas cepacia 17616
25. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
26. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strain
27. Outcome of Burkholderia (Pseudomonas) cepacia colonization in children with cystic fibrosis following a hospital outbreak
28. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients
29. Lack of nosocomial cross-infection by Burkholderia cepacia in Danish cystic fibrosis patients
30. Cross infection between cystic fibrosis patients colonized with Burkholderia cepacia